S. Cao
Grace Cancer Drug Center
Roswell Park Cancer Institute
Buffalo
New York 14263
USA
Name/email consistency: high
- alpha-fluoro-beta-alanine: effects on the antitumor activity and toxicity of 5-fluorouracil. Cao, S., Baccanari, D.P., Rustum, Y.M., Davis, S.T., Tansik, R.L., Porter, D.J., Spector, T. Biochem. Pharmacol. (2000)
- Persistent induction of apoptosis and suppression of mitosis as the basis for curative therapy with S-1, an oral 5-fluorouracil prodrug in a colorectal tumor model. Cao, S., Lu, K., Tóth, K., Slocum, H.K., Shirasaka, T., Rustum, Y.M. Clin. Cancer Res. (1999)
- Antitumor activity of ZD1694 (tomudex) against human head and neck cancer in nude mouse models: role of dosing schedule and plasma thymidine. Cao, S., McGuire, J.J., Rustum, Y.M. Clin. Cancer Res. (1999)
- Interleukin 15 protects against toxicity and potentiates antitumor activity of 5-fluorouracil alone and in combination with leucovorin in rats bearing colorectal cancer. Cao, S., Troutt, A.B., Rustum, Y.M. Cancer Res. (1998)
- Interleukin 15 offers selective protection from irinotecan-induced intestinal toxicity in a preclinical animal model. Cao, S., Black, J.D., Troutt, A.B., Rustum, Y.M. Cancer Res. (1998)